Literature DB >> 16969634

Decreased protein S activity is related to the disease activity of Behcet's disease.

Seong Ryul Kwon1, Mie Jin Lim, Shin Goo Park, Yeon Sook Moon, Won Park.   

Abstract

We wanted to see whether the active inflammation in Behcet's disease (BD) can cause a thrombotic disorder by decreasing the protein S (PS) activity, and we evaluated the relationship between the decreased PS activity and the disease activity of BD. We included 122 patients with BD whose PS activity levels were measured. In 51 patients, the PS activity was measured again when there were changes in the number of items of "The Behcet's Disease Current Activity Form (BDCAF)". The thrombosis rate was 2.5% (3/122), and the PS activity was low in all three of the patients with thrombosis. The incidence of low PS activity in the total 122 BD patients was 27% (33/122). The incidence of the low PS activity in the active BD patients was 33.7% (31/92), and this was significantly more frequent than in the inactive BD patients, (6.7%, 2/30) (chi(2)-test, P value = 0.0038). The decrease of PS activity had good correlation with the increase of the number of BDCAF items (r = -0.351, P value = 0.012). The PS activity decrease is related to the BD activity. The low PS activity can be the risk factor for thrombotic disorder and also the activity marker for BD and other inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16969634     DOI: 10.1007/s00296-006-0214-4

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  33 in total

Review 1.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

2.  Comparison of coagulation parameters for healthy subjects and Behçet disease patients with and without vascular involvement.

Authors:  N Sengül; S Demirer; M A Yerdel; G Terzioğlu; B Akin; A Gürler; A Tüzüner
Journal:  World J Surg       Date:  2000-12       Impact factor: 3.352

Review 3.  Behçet's Disease.

Authors:  V G Kaklamani; G Vaiopoulos; P G Kaklamanis
Journal:  Semin Arthritis Rheum       Date:  1998-02       Impact factor: 5.532

4.  Factor V Leiden mutation in patients with Behçet's disease.

Authors:  A F Oner; A Gürgey; A Gürler; L Mesci
Journal:  J Rheumatol       Date:  1998-03       Impact factor: 4.666

5.  Cerebral venous thrombosis in Behçet's disease: clinical study and long-term follow-up of 25 cases.

Authors:  B Wechsler; M Vidailhet; J C Piette; M G Bousser; B Dell Isola; O Blétry; P Godeau
Journal:  Neurology       Date:  1992-03       Impact factor: 9.910

6.  Increased advanced oxidation protein products in Behçet's disease: a new activity marker?

Authors:  C Yazici; K Köse; M Caliş; M DemIr; M Kirnap; F Ateş
Journal:  Br J Dermatol       Date:  2004-07       Impact factor: 9.302

7.  Protein S deficiency in men with long-term human immunodeficiency virus infection.

Authors:  C P Stahl; C S Wideman; T J Spira; E C Haff; G J Hixon; B L Evatt
Journal:  Blood       Date:  1993-04-01       Impact factor: 22.113

8.  Acquired free protein S deficiency associated with multiple myeloma: a case report.

Authors:  S R Deitcher; J K Erban; S A Limentani
Journal:  Am J Hematol       Date:  1996-04       Impact factor: 10.047

9.  Varicella and thrombotic complications associated with transient protein C and protein S deficiencies in children.

Authors:  P Nguyên; J Reynaud; P Pouzol; M Munzer; O Richard; P François
Journal:  Eur J Pediatr       Date:  1994-09       Impact factor: 3.183

10.  Isolation and sequence of the cDNA for human protein S, a regulator of blood coagulation.

Authors:  A Lundwall; W Dackowski; E Cohen; M Shaffer; A Mahr; B Dahlbäck; J Stenflo; R Wydro
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

View more
  5 in total

Review 1.  Calprotectin in rheumatic diseases.

Authors:  Francesca Ometto; Lara Friso; Davide Astorri; Costantino Botsios; Bernd Raffeiner; Leonardo Punzi; Andrea Doria
Journal:  Exp Biol Med (Maywood)       Date:  2016-01-01

2.  Thrombosis in Behçet's disease: a Behçet's disease patient with complete thrombotic obstruction of IVC and both iliac veins and decreased protein S activity.

Authors:  Harin Jeong; In-Kyung Yoo; Sungjae Choi; Youngho Lee; Jongdae Ji; Gwankyu Song; Hwanhoon Chung; Seunghwa Lee; Won-Min Jo
Journal:  Rheumatol Int       Date:  2011-12-27       Impact factor: 2.631

Review 3.  Outcome measures used in clinical trials for Behçet syndrome: a systematic review.

Authors:  Gulen Hatemi; Peter A Merkel; Vedat Hamuryudan; Maarten Boers; Haner Direskeneli; Sibel Z Aydin; Hasan Yazici
Journal:  J Rheumatol       Date:  2014-02-01       Impact factor: 4.666

4.  Behçet's disease complicated with thrombosis: a report of 93 Chinese cases.

Authors:  Xiuhua Wu; Guohua Li; Xinxiang Huang; Li Wang; Wanli Liu; Yan Zhao; Wenjie Zheng
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

5.  Extensive thrombosis in a patient with familial Mediterranean fever, despite hyperimmunoglobulin D state in serum. [corrected].

Authors:  Kowoon Joo; Won Park; Moon-Hyun Chung; Mie-Jin Lim; Kyong Hee Jung; Yoonseok Heo; Seong-Ryul Kwon
Journal:  J Korean Med Sci       Date:  2013-01-29       Impact factor: 2.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.